Non-liquid vitamin compositions
Abstract
A method for orally administering vitamin preparations is described which combine vitamin B 12 (B 12 , cobalamin) and folic acid (folate), with and without pyridoxine (B 6 ), for preventing and treating elevated serum homocysteine (HC), cystathionine (CT), methylmalonic acid (MMA), or 2-methylcitric acid (2-MCA) levels. These metabolites have been shown to be indicative of B 12 and/or folic acid deficiencies. Further, it is likely that a B 6 deficiency may be present with a B 12 or folate deficiency. The method of the invention is also for use in lowering serum HC, CT, MMA, or 2-MCA in patients with or at risk for neuropsychiatric, vascular, renal or hematologic diseases. The method of the present invention eliminates the costly and time consuming steps of distinguishing between vitamin deficiencies once a deficiency is found by measurement of serum metabolite levels. The present invention is of particular benefit to the populations at risk for elevated serum metabolite levels, such as the people over the age of 65, and populations that have or are at risk for neuropsychiatric, vascular, renal and hematologic diseases.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A non-liquid formulation, comprising 2-10 mg vitamin B12 and 0.1-0.4 mg folic acid.
2 . The formulation of claim 1 , having approximately 0.4 mg folic acid.
3 . The formulation of claim 2 , having approximately 2 mg vitamin B12.
4 . A non-liquid formulation, comprising 2-10 mg vitamin B12 and 0.1-0.4 mg folic acid and 5-75 mg vitamin B6.
5 . The formulation of claim 4 , having approximately 25 mg vitamin B6.
6 . The formulation of claim 5 , having approximately 0.4 mg folic acid.
7 . The formulation of claim 6 , having approximately 2 mg vitamin B12.
8 . A non-liquid formulation, comprising 2-10 mg vitamin B12 and 0.4-10 mg folic acid.
9 . The formulation of claim 8 , having approximately 1 mg folic acid.
10 . The formulation of claim 8 , having approximately 2 mg folic acid.
11 . The formulation of claim 8 , having approximately 2.5 mg folic acid.
12 . The formulation of claim 8 , having approximately 2 mg vitamin B12.
13 . The formulation of claim 12 , having approximately 1 mg folic acid.
14 . The formulation of claim 12 , having approximately 2 mg folic acid.
15 . The formulation of claim 12 , having approximately 2.5 mg folic acid.
16 . A non-liquid formulation, comprising 2-10 mg vitamin B12 and 0.4-10 mg folic acid and 5-75 mg vitamin B6.
17 . The formulation of claim 16 , having approximately 25 mg vitamin B6.
18 . The formulation of claim 17 , having approximately 1 mg folic acid.
19 . The formulation of claim 17 , having approximately 2 mg folic acid.
20 . The formulation of claim 17 , having approximately 2.5 mg folic acid.
21 . The formulation of claim 16 , having approximately 2 mg vitamin B12.
22 . The formulation of claim 21 , having approximately 25 mg vitamin B6.
23 . The formulation of claim 22 , having approximately 1 mg folic acid.
24 . The formulation of claim 22 , having approximately 2 mg folic acid.
25 . The formulation of claim 22 , having approximately 2.5 mg folic acid.
26 . A non-liquid formulation, comprising 0.3-10 mg vitamin B12 and 2-10 mg folic acid.
27 . The formulation of claim 26 , having approximately 2 mg folic acid.
28 . The formulation of claim 26 , having approximately 2.5 mg folic acid.
29 . The formulation of claim 27 , having approximately 1 mg vitamin B12.
30 . The formulation of claim 28 , having approximately 1 mg vitamin B12.
31 . A non-liquid formulation, comprising 0.3-10 mg vitamin B12 and 2-10 mg folic acid and 5-75 mg vitamin B6.
32 . The formulation of claim 31 , having approximately 25 mg vitamin B6.
33 . The formulation of claim 32 , having approximately 2 mg folic acid.
34 . The formulation of claim 32 , having approximately 2.5 mg folic acid.
35 . The formulation of claim 31 , having approximately 2 mg folic acid.
36 . The formulation of claim 31 , having approximately 2.5 mg folic acid.
37 . The formulation of claim 31 , having approximately 1 mg vitamin B12.
38 . The formulation of claim 37 , having approximately 25 mg vitamin B6.
39 . The formulation of claim 38 , having approximately 2 mg folic acid.
40 . The formulation of claim 38 , having approximately 2.5 mg folic acid.Join the waitlist — get patent alerts
Track US2004266724A9 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.